nodes	percent_of_prediction	percent_of_DWPC	metapath
Vidarabine—Head pressure—Donepezil—Alzheimer's disease	0.063	0.0962	CcSEcCtD
Vidarabine—Sinoatrial block—Donepezil—Alzheimer's disease	0.0362	0.0552	CcSEcCtD
Vidarabine—Device capturing issue—Donepezil—Alzheimer's disease	0.0362	0.0552	CcSEcCtD
Vidarabine—DPP4—blood vessel—Alzheimer's disease	0.0155	0.127	CbGeAlD
Vidarabine—Supraventricular extrasystoles—Galantamine—Alzheimer's disease	0.0131	0.0201	CcSEcCtD
Vidarabine—Atrioventricular block first degree—Galantamine—Alzheimer's disease	0.0129	0.0197	CcSEcCtD
Vidarabine—Supraventricular extrasystoles—Donepezil—Alzheimer's disease	0.0102	0.0156	CcSEcCtD
Vidarabine—ADORA2A—forebrain—Alzheimer's disease	0.00942	0.0771	CbGeAlD
Vidarabine—DPP4—embryo—Alzheimer's disease	0.00927	0.0759	CbGeAlD
Vidarabine—Haemorrhage intracranial—Donepezil—Alzheimer's disease	0.00925	0.0141	CcSEcCtD
Vidarabine—Supraventricular extrasystoles—Rivastigmine—Alzheimer's disease	0.00904	0.0138	CcSEcCtD
Vidarabine—Coronary artery disease—Memantine—Alzheimer's disease	0.00871	0.0133	CcSEcCtD
Vidarabine—ADORA2A—telencephalon—Alzheimer's disease	0.00866	0.0709	CbGeAlD
Vidarabine—Coronary artery disease—Rivastigmine—Alzheimer's disease	0.00852	0.013	CcSEcCtD
Vidarabine—ADK—forebrain—Alzheimer's disease	0.00846	0.0692	CbGeAlD
Vidarabine—Haemorrhage intracranial—Memantine—Alzheimer's disease	0.00839	0.0128	CcSEcCtD
Vidarabine—Haemorrhage intracranial—Rivastigmine—Alzheimer's disease	0.00821	0.0125	CcSEcCtD
Vidarabine—Grand mal convulsion—Donepezil—Alzheimer's disease	0.00797	0.0122	CcSEcCtD
Vidarabine—ADK—telencephalon—Alzheimer's disease	0.00778	0.0637	CbGeAlD
Vidarabine—Grand mal convulsion—Memantine—Alzheimer's disease	0.00723	0.0111	CcSEcCtD
Vidarabine—Micturition urgency—Donepezil—Alzheimer's disease	0.00668	0.0102	CcSEcCtD
Vidarabine—Myocardial ischaemia—Galantamine—Alzheimer's disease	0.00609	0.0093	CcSEcCtD
Vidarabine—Micturition urgency—Rivastigmine—Alzheimer's disease	0.00594	0.00907	CcSEcCtD
Vidarabine—ADA—nervous system—Alzheimer's disease	0.00562	0.046	CbGeAlD
Vidarabine—Hyperventilation—Donepezil—Alzheimer's disease	0.00551	0.00842	CcSEcCtD
Vidarabine—ADA—central nervous system—Alzheimer's disease	0.00541	0.0443	CbGeAlD
Vidarabine—ADORA2A—nervous system—Alzheimer's disease	0.00511	0.0418	CbGeAlD
Vidarabine—Atrioventricular block—Galantamine—Alzheimer's disease	0.00505	0.00771	CcSEcCtD
Vidarabine—ADORA2A—central nervous system—Alzheimer's disease	0.00492	0.0403	CbGeAlD
Vidarabine—Torsade de pointes—Memantine—Alzheimer's disease	0.00491	0.0075	CcSEcCtD
Vidarabine—Hyperventilation—Rivastigmine—Alzheimer's disease	0.0049	0.00748	CcSEcCtD
Vidarabine—Ventricular tachycardia—Galantamine—Alzheimer's disease	0.00489	0.00748	CcSEcCtD
Vidarabine—Adenosine monophosphate—CREB1—Alzheimer's disease	0.00488	0.419	CrCbGaD
Vidarabine—ADORA2A—cerebellum—Alzheimer's disease	0.00481	0.0394	CbGeAlD
Vidarabine—Ventricular arrhythmia—Memantine—Alzheimer's disease	0.00465	0.00711	CcSEcCtD
Vidarabine—ADK—nervous system—Alzheimer's disease	0.00459	0.0376	CbGeAlD
Vidarabine—Numbness—Donepezil—Alzheimer's disease	0.00458	0.00699	CcSEcCtD
Vidarabine—DPP4—nervous system—Alzheimer's disease	0.00445	0.0364	CbGeAlD
Vidarabine—ADK—central nervous system—Alzheimer's disease	0.00442	0.0362	CbGeAlD
Vidarabine—Sensory loss—Donepezil—Alzheimer's disease	0.00438	0.00669	CcSEcCtD
Vidarabine—ADK—cerebellum—Alzheimer's disease	0.00432	0.0354	CbGeAlD
Vidarabine—ADA—brain—Alzheimer's disease	0.0043	0.0352	CbGeAlD
Vidarabine—DPP4—central nervous system—Alzheimer's disease	0.00429	0.0351	CbGeAlD
Vidarabine—Ventricular extrasystoles—Donepezil—Alzheimer's disease	0.0042	0.00642	CcSEcCtD
Vidarabine—Myocardial ischaemia—Rivastigmine—Alzheimer's disease	0.00419	0.0064	CcSEcCtD
Vidarabine—Numbness—Memantine—Alzheimer's disease	0.00415	0.00635	CcSEcCtD
Vidarabine—Extrasystoles—Memantine—Alzheimer's disease	0.00409	0.00625	CcSEcCtD
Vidarabine—Apnoea—Memantine—Alzheimer's disease	0.00406	0.00621	CcSEcCtD
Vidarabine—Extrasystoles—Rivastigmine—Alzheimer's disease	0.004	0.00612	CcSEcCtD
Vidarabine—Sensory loss—Memantine—Alzheimer's disease	0.00398	0.00607	CcSEcCtD
Vidarabine—Apnoea—Rivastigmine—Alzheimer's disease	0.00397	0.00607	CcSEcCtD
Vidarabine—Atrioventricular block—Donepezil—Alzheimer's disease	0.00391	0.00597	CcSEcCtD
Vidarabine—ADORA2A—brain—Alzheimer's disease	0.00391	0.032	CbGeAlD
Vidarabine—Atrial fibrillation—Galantamine—Alzheimer's disease	0.00375	0.00573	CcSEcCtD
Vidarabine—Cardiac failure—Galantamine—Alzheimer's disease	0.00364	0.00556	CcSEcCtD
Vidarabine—Cerebrovascular accident—Galantamine—Alzheimer's disease	0.00363	0.00554	CcSEcCtD
Vidarabine—Atrioventricular block—Memantine—Alzheimer's disease	0.00355	0.00542	CcSEcCtD
Vidarabine—ADK—brain—Alzheimer's disease	0.00351	0.0287	CbGeAlD
Vidarabine—Respiratory failure—Memantine—Alzheimer's disease	0.00351	0.00536	CcSEcCtD
Vidarabine—Atrioventricular block—Rivastigmine—Alzheimer's disease	0.00347	0.00531	CcSEcCtD
Vidarabine—Respiratory failure—Rivastigmine—Alzheimer's disease	0.00343	0.00524	CcSEcCtD
Vidarabine—DPP4—brain—Alzheimer's disease	0.0034	0.0279	CbGeAlD
Vidarabine—Abdominal discomfort—Galantamine—Alzheimer's disease	0.00294	0.0045	CcSEcCtD
Vidarabine—Atrial fibrillation—Donepezil—Alzheimer's disease	0.00291	0.00444	CcSEcCtD
Vidarabine—Pollakiuria—Galantamine—Alzheimer's disease	0.00284	0.00433	CcSEcCtD
Vidarabine—Cardiac failure—Donepezil—Alzheimer's disease	0.00282	0.00431	CcSEcCtD
Vidarabine—Cerebrovascular accident—Donepezil—Alzheimer's disease	0.00281	0.00429	CcSEcCtD
Vidarabine—Adenosine triphosphate—ABCA1—Alzheimer's disease	0.00273	0.234	CrCbGaD
Vidarabine—Affect lability—Donepezil—Alzheimer's disease	0.00271	0.00414	CcSEcCtD
Vidarabine—Atrial fibrillation—Memantine—Alzheimer's disease	0.00264	0.00403	CcSEcCtD
Vidarabine—Mood swings—Donepezil—Alzheimer's disease	0.00261	0.00399	CcSEcCtD
Vidarabine—Atrial fibrillation—Rivastigmine—Alzheimer's disease	0.00258	0.00394	CcSEcCtD
Vidarabine—Cardiac failure—Memantine—Alzheimer's disease	0.00256	0.00391	CcSEcCtD
Vidarabine—Cerebrovascular accident—Memantine—Alzheimer's disease	0.00255	0.0039	CcSEcCtD
Vidarabine—Cardiac failure—Rivastigmine—Alzheimer's disease	0.00251	0.00383	CcSEcCtD
Vidarabine—Bradycardia—Galantamine—Alzheimer's disease	0.0025	0.00382	CcSEcCtD
Vidarabine—Cerebrovascular accident—Rivastigmine—Alzheimer's disease	0.0025	0.00381	CcSEcCtD
Vidarabine—Affect lability—Memantine—Alzheimer's disease	0.00246	0.00376	CcSEcCtD
Vidarabine—Affect lability—Rivastigmine—Alzheimer's disease	0.00241	0.00368	CcSEcCtD
Vidarabine—Cardiac arrest—Memantine—Alzheimer's disease	0.00238	0.00363	CcSEcCtD
Vidarabine—Mood swings—Memantine—Alzheimer's disease	0.00237	0.00362	CcSEcCtD
Vidarabine—Cardiac arrest—Rivastigmine—Alzheimer's disease	0.00233	0.00355	CcSEcCtD
Vidarabine—Mood swings—Rivastigmine—Alzheimer's disease	0.00232	0.00354	CcSEcCtD
Vidarabine—Tinnitus—Galantamine—Alzheimer's disease	0.00229	0.0035	CcSEcCtD
Vidarabine—Abdominal discomfort—Donepezil—Alzheimer's disease	0.00228	0.00349	CcSEcCtD
Vidarabine—Flushing—Galantamine—Alzheimer's disease	0.00228	0.00349	CcSEcCtD
Vidarabine—Cardiac disorder—Galantamine—Alzheimer's disease	0.00228	0.00349	CcSEcCtD
Vidarabine—Pollakiuria—Donepezil—Alzheimer's disease	0.0022	0.00336	CcSEcCtD
Vidarabine—Arrhythmia—Galantamine—Alzheimer's disease	0.0022	0.00335	CcSEcCtD
Vidarabine—Bronchospasm—Memantine—Alzheimer's disease	0.00213	0.00325	CcSEcCtD
Vidarabine—Tension—Galantamine—Alzheimer's disease	0.0021	0.00321	CcSEcCtD
Vidarabine—Dysgeusia—Galantamine—Alzheimer's disease	0.0021	0.0032	CcSEcCtD
Vidarabine—Acute coronary syndrome—Donepezil—Alzheimer's disease	0.00209	0.0032	CcSEcCtD
Vidarabine—Myocardial infarction—Donepezil—Alzheimer's disease	0.00208	0.00318	CcSEcCtD
Vidarabine—Bronchospasm—Rivastigmine—Alzheimer's disease	0.00208	0.00318	CcSEcCtD
Vidarabine—Nervousness—Galantamine—Alzheimer's disease	0.00208	0.00318	CcSEcCtD
Vidarabine—Back pain—Galantamine—Alzheimer's disease	0.00207	0.00316	CcSEcCtD
Vidarabine—Glucosamine—TNF—Alzheimer's disease	0.00204	0.175	CrCbGaD
Vidarabine—Sweating—Donepezil—Alzheimer's disease	0.00203	0.00311	CcSEcCtD
Vidarabine—Vision blurred—Galantamine—Alzheimer's disease	0.00202	0.00308	CcSEcCtD
Vidarabine—Tremor—Galantamine—Alzheimer's disease	0.002	0.00306	CcSEcCtD
Vidarabine—Adenosine triphosphate—AKT1—Alzheimer's disease	0.002	0.172	CrCbGaD
Vidarabine—Pollakiuria—Memantine—Alzheimer's disease	0.002	0.00305	CcSEcCtD
Vidarabine—Agitation—Galantamine—Alzheimer's disease	0.00197	0.003	CcSEcCtD
Vidarabine—Pollakiuria—Rivastigmine—Alzheimer's disease	0.00195	0.00298	CcSEcCtD
Vidarabine—Bradycardia—Donepezil—Alzheimer's disease	0.00194	0.00296	CcSEcCtD
Vidarabine—Syncope—Galantamine—Alzheimer's disease	0.00192	0.00293	CcSEcCtD
Vidarabine—Acute coronary syndrome—Memantine—Alzheimer's disease	0.0019	0.0029	CcSEcCtD
Vidarabine—Hypoaesthesia—Donepezil—Alzheimer's disease	0.0019	0.0029	CcSEcCtD
Vidarabine—Palpitations—Galantamine—Alzheimer's disease	0.00189	0.00289	CcSEcCtD
Vidarabine—Myocardial infarction—Memantine—Alzheimer's disease	0.00189	0.00289	CcSEcCtD
Vidarabine—Drowsiness—Rivastigmine—Alzheimer's disease	0.00188	0.00288	CcSEcCtD
Vidarabine—Loss of consciousness—Galantamine—Alzheimer's disease	0.00188	0.00287	CcSEcCtD
Vidarabine—Cough—Galantamine—Alzheimer's disease	0.00187	0.00285	CcSEcCtD
Vidarabine—Acute coronary syndrome—Rivastigmine—Alzheimer's disease	0.00186	0.00284	CcSEcCtD
Vidarabine—Convulsion—Galantamine—Alzheimer's disease	0.00185	0.00283	CcSEcCtD
Vidarabine—Myocardial infarction—Rivastigmine—Alzheimer's disease	0.00185	0.00282	CcSEcCtD
Vidarabine—Hypertension—Galantamine—Alzheimer's disease	0.00185	0.00282	CcSEcCtD
Vidarabine—Chest pain—Galantamine—Alzheimer's disease	0.00182	0.00278	CcSEcCtD
Vidarabine—Anxiety—Galantamine—Alzheimer's disease	0.00182	0.00277	CcSEcCtD
Vidarabine—Sweating—Rivastigmine—Alzheimer's disease	0.00181	0.00276	CcSEcCtD
Vidarabine—Discomfort—Galantamine—Alzheimer's disease	0.0018	0.00275	CcSEcCtD
Vidarabine—Dry mouth—Galantamine—Alzheimer's disease	0.00178	0.00272	CcSEcCtD
Vidarabine—Tinnitus—Donepezil—Alzheimer's disease	0.00178	0.00271	CcSEcCtD
Vidarabine—Bradycardia—Memantine—Alzheimer's disease	0.00176	0.00269	CcSEcCtD
Vidarabine—Bradycardia—Rivastigmine—Alzheimer's disease	0.00172	0.00263	CcSEcCtD
Vidarabine—Hypoaesthesia—Memantine—Alzheimer's disease	0.00172	0.00263	CcSEcCtD
Vidarabine—Shock—Galantamine—Alzheimer's disease	0.00172	0.00262	CcSEcCtD
Vidarabine—Tachycardia—Galantamine—Alzheimer's disease	0.0017	0.0026	CcSEcCtD
Vidarabine—Arrhythmia—Donepezil—Alzheimer's disease	0.0017	0.0026	CcSEcCtD
Vidarabine—Hyperhidrosis—Galantamine—Alzheimer's disease	0.00169	0.00258	CcSEcCtD
Vidarabine—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.00168	0.00257	CcSEcCtD
Vidarabine—Hypotension—Galantamine—Alzheimer's disease	0.00163	0.00249	CcSEcCtD
Vidarabine—Tension—Donepezil—Alzheimer's disease	0.00163	0.00249	CcSEcCtD
Vidarabine—Dysgeusia—Donepezil—Alzheimer's disease	0.00162	0.00248	CcSEcCtD
Vidarabine—Tinnitus—Memantine—Alzheimer's disease	0.00161	0.00246	CcSEcCtD
Vidarabine—Nervousness—Donepezil—Alzheimer's disease	0.00161	0.00246	CcSEcCtD
Vidarabine—Cardiac disorder—Memantine—Alzheimer's disease	0.00161	0.00245	CcSEcCtD
Vidarabine—Flushing—Memantine—Alzheimer's disease	0.00161	0.00245	CcSEcCtD
Vidarabine—Back pain—Donepezil—Alzheimer's disease	0.0016	0.00245	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.00159	0.00243	CcSEcCtD
Vidarabine—Tinnitus—Rivastigmine—Alzheimer's disease	0.00158	0.00241	CcSEcCtD
Vidarabine—Flushing—Rivastigmine—Alzheimer's disease	0.00157	0.0024	CcSEcCtD
Vidarabine—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.00157	0.0024	CcSEcCtD
Vidarabine—Paraesthesia—Galantamine—Alzheimer's disease	0.00157	0.0024	CcSEcCtD
Vidarabine—Vision blurred—Donepezil—Alzheimer's disease	0.00156	0.00239	CcSEcCtD
Vidarabine—Mediastinal disorder—Memantine—Alzheimer's disease	0.00156	0.00238	CcSEcCtD
Vidarabine—Tremor—Donepezil—Alzheimer's disease	0.00155	0.00237	CcSEcCtD
Vidarabine—Somnolence—Galantamine—Alzheimer's disease	0.00155	0.00237	CcSEcCtD
Vidarabine—Arrhythmia—Memantine—Alzheimer's disease	0.00155	0.00236	CcSEcCtD
Vidarabine—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.00152	0.00233	CcSEcCtD
Vidarabine—Agitation—Donepezil—Alzheimer's disease	0.00152	0.00233	CcSEcCtD
Vidarabine—Arrhythmia—Rivastigmine—Alzheimer's disease	0.00151	0.00231	CcSEcCtD
Vidarabine—Syncope—Donepezil—Alzheimer's disease	0.00149	0.00227	CcSEcCtD
Vidarabine—Tension—Memantine—Alzheimer's disease	0.00148	0.00226	CcSEcCtD
Vidarabine—Dysgeusia—Memantine—Alzheimer's disease	0.00147	0.00225	CcSEcCtD
Vidarabine—Nervousness—Memantine—Alzheimer's disease	0.00146	0.00223	CcSEcCtD
Vidarabine—Loss of consciousness—Donepezil—Alzheimer's disease	0.00146	0.00223	CcSEcCtD
Vidarabine—Back pain—Memantine—Alzheimer's disease	0.00146	0.00223	CcSEcCtD
Vidarabine—Cough—Donepezil—Alzheimer's disease	0.00145	0.00221	CcSEcCtD
Vidarabine—Tension—Rivastigmine—Alzheimer's disease	0.00145	0.00221	CcSEcCtD
Vidarabine—Dysgeusia—Rivastigmine—Alzheimer's disease	0.00144	0.0022	CcSEcCtD
Vidarabine—Convulsion—Donepezil—Alzheimer's disease	0.00144	0.0022	CcSEcCtD
Vidarabine—Hypertension—Donepezil—Alzheimer's disease	0.00143	0.00219	CcSEcCtD
Vidarabine—Nervousness—Rivastigmine—Alzheimer's disease	0.00143	0.00219	CcSEcCtD
Vidarabine—Back pain—Rivastigmine—Alzheimer's disease	0.00142	0.00218	CcSEcCtD
Vidarabine—Vision blurred—Memantine—Alzheimer's disease	0.00142	0.00217	CcSEcCtD
Vidarabine—Chest pain—Donepezil—Alzheimer's disease	0.00141	0.00216	CcSEcCtD
Vidarabine—Tremor—Memantine—Alzheimer's disease	0.00141	0.00216	CcSEcCtD
Vidarabine—Anxiety—Donepezil—Alzheimer's disease	0.00141	0.00215	CcSEcCtD
Vidarabine—Discomfort—Donepezil—Alzheimer's disease	0.00139	0.00213	CcSEcCtD
Vidarabine—Vision blurred—Rivastigmine—Alzheimer's disease	0.00139	0.00212	CcSEcCtD
Vidarabine—Agitation—Memantine—Alzheimer's disease	0.00138	0.00211	CcSEcCtD
Vidarabine—Dry mouth—Donepezil—Alzheimer's disease	0.00138	0.00211	CcSEcCtD
Vidarabine—Tremor—Rivastigmine—Alzheimer's disease	0.00138	0.00211	CcSEcCtD
Vidarabine—Agitation—Rivastigmine—Alzheimer's disease	0.00135	0.00207	CcSEcCtD
Vidarabine—Syncope—Memantine—Alzheimer's disease	0.00135	0.00206	CcSEcCtD
Vidarabine—Shock—Donepezil—Alzheimer's disease	0.00133	0.00203	CcSEcCtD
Vidarabine—Palpitations—Memantine—Alzheimer's disease	0.00133	0.00203	CcSEcCtD
Vidarabine—Loss of consciousness—Memantine—Alzheimer's disease	0.00132	0.00202	CcSEcCtD
Vidarabine—Syncope—Rivastigmine—Alzheimer's disease	0.00132	0.00202	CcSEcCtD
Vidarabine—Cough—Memantine—Alzheimer's disease	0.00131	0.00201	CcSEcCtD
Vidarabine—Hyperhidrosis—Donepezil—Alzheimer's disease	0.00131	0.002	CcSEcCtD
Vidarabine—Convulsion—Memantine—Alzheimer's disease	0.0013	0.00199	CcSEcCtD
Vidarabine—Palpitations—Rivastigmine—Alzheimer's disease	0.0013	0.00199	CcSEcCtD
Vidarabine—Hypertension—Memantine—Alzheimer's disease	0.0013	0.00199	CcSEcCtD
Vidarabine—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.00129	0.00198	CcSEcCtD
Vidarabine—Hypersensitivity—Galantamine—Alzheimer's disease	0.00129	0.00197	CcSEcCtD
Vidarabine—Cough—Rivastigmine—Alzheimer's disease	0.00129	0.00196	CcSEcCtD
Vidarabine—Chest pain—Memantine—Alzheimer's disease	0.00128	0.00196	CcSEcCtD
Vidarabine—Anxiety—Memantine—Alzheimer's disease	0.00128	0.00195	CcSEcCtD
Vidarabine—Convulsion—Rivastigmine—Alzheimer's disease	0.00128	0.00195	CcSEcCtD
Vidarabine—Hypertension—Rivastigmine—Alzheimer's disease	0.00127	0.00194	CcSEcCtD
Vidarabine—Discomfort—Memantine—Alzheimer's disease	0.00127	0.00193	CcSEcCtD
Vidarabine—Hypotension—Donepezil—Alzheimer's disease	0.00126	0.00193	CcSEcCtD
Vidarabine—Chest pain—Rivastigmine—Alzheimer's disease	0.00125	0.00192	CcSEcCtD
Vidarabine—Dry mouth—Memantine—Alzheimer's disease	0.00125	0.00192	CcSEcCtD
Vidarabine—Asthenia—Galantamine—Alzheimer's disease	0.00125	0.00191	CcSEcCtD
Vidarabine—Anxiety—Rivastigmine—Alzheimer's disease	0.00125	0.00191	CcSEcCtD
Vidarabine—Discomfort—Rivastigmine—Alzheimer's disease	0.00124	0.00189	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.00123	0.00188	CcSEcCtD
Vidarabine—Dry mouth—Rivastigmine—Alzheimer's disease	0.00123	0.00187	CcSEcCtD
Vidarabine—Paraesthesia—Donepezil—Alzheimer's disease	0.00122	0.00186	CcSEcCtD
Vidarabine—Shock—Memantine—Alzheimer's disease	0.00121	0.00185	CcSEcCtD
Vidarabine—Dyspnoea—Donepezil—Alzheimer's disease	0.00121	0.00184	CcSEcCtD
Vidarabine—Somnolence—Donepezil—Alzheimer's disease	0.0012	0.00184	CcSEcCtD
Vidarabine—Tachycardia—Memantine—Alzheimer's disease	0.0012	0.00183	CcSEcCtD
Vidarabine—Hyperhidrosis—Memantine—Alzheimer's disease	0.00119	0.00181	CcSEcCtD
Vidarabine—Shock—Rivastigmine—Alzheimer's disease	0.00118	0.00181	CcSEcCtD
Vidarabine—Tachycardia—Rivastigmine—Alzheimer's disease	0.00117	0.00179	CcSEcCtD
Vidarabine—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.00116	0.00178	CcSEcCtD
Vidarabine—Pain—Donepezil—Alzheimer's disease	0.00116	0.00177	CcSEcCtD
Vidarabine—Dizziness—Galantamine—Alzheimer's disease	0.00115	0.00176	CcSEcCtD
Vidarabine—Hypotension—Memantine—Alzheimer's disease	0.00115	0.00175	CcSEcCtD
Vidarabine—Hypotension—Rivastigmine—Alzheimer's disease	0.00112	0.00172	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.00112	0.00171	CcSEcCtD
Vidarabine—Vomiting—Galantamine—Alzheimer's disease	0.00111	0.0017	CcSEcCtD
Vidarabine—Paraesthesia—Memantine—Alzheimer's disease	0.0011	0.00169	CcSEcCtD
Vidarabine—Rash—Galantamine—Alzheimer's disease	0.0011	0.00168	CcSEcCtD
Vidarabine—Dermatitis—Galantamine—Alzheimer's disease	0.0011	0.00168	CcSEcCtD
Vidarabine—Dyspnoea—Memantine—Alzheimer's disease	0.0011	0.00167	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.0011	0.00167	CcSEcCtD
Vidarabine—Headache—Galantamine—Alzheimer's disease	0.00109	0.00167	CcSEcCtD
Vidarabine—Somnolence—Memantine—Alzheimer's disease	0.00109	0.00167	CcSEcCtD
Vidarabine—Paraesthesia—Rivastigmine—Alzheimer's disease	0.00108	0.00165	CcSEcCtD
Vidarabine—Urticaria—Donepezil—Alzheimer's disease	0.00108	0.00164	CcSEcCtD
Vidarabine—Dyspnoea—Rivastigmine—Alzheimer's disease	0.00107	0.00164	CcSEcCtD
Vidarabine—Somnolence—Rivastigmine—Alzheimer's disease	0.00107	0.00163	CcSEcCtD
Vidarabine—Pain—Memantine—Alzheimer's disease	0.00105	0.00161	CcSEcCtD
Vidarabine—Nausea—Galantamine—Alzheimer's disease	0.00104	0.00158	CcSEcCtD
Vidarabine—Pain—Rivastigmine—Alzheimer's disease	0.00103	0.00157	CcSEcCtD
Vidarabine—Hypersensitivity—Donepezil—Alzheimer's disease	0.000997	0.00152	CcSEcCtD
Vidarabine—Urticaria—Memantine—Alzheimer's disease	0.000976	0.00149	CcSEcCtD
Vidarabine—Asthenia—Donepezil—Alzheimer's disease	0.000971	0.00148	CcSEcCtD
Vidarabine—Urticaria—Rivastigmine—Alzheimer's disease	0.000955	0.00146	CcSEcCtD
Vidarabine—Hypersensitivity—Memantine—Alzheimer's disease	0.000905	0.00138	CcSEcCtD
Vidarabine—Dizziness—Donepezil—Alzheimer's disease	0.000895	0.00137	CcSEcCtD
Vidarabine—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000886	0.00135	CcSEcCtD
Vidarabine—Asthenia—Memantine—Alzheimer's disease	0.000882	0.00135	CcSEcCtD
Vidarabine—Asthenia—Rivastigmine—Alzheimer's disease	0.000862	0.00132	CcSEcCtD
Vidarabine—Vomiting—Donepezil—Alzheimer's disease	0.00086	0.00131	CcSEcCtD
Vidarabine—Rash—Donepezil—Alzheimer's disease	0.000853	0.0013	CcSEcCtD
Vidarabine—Dermatitis—Donepezil—Alzheimer's disease	0.000852	0.0013	CcSEcCtD
Vidarabine—Headache—Donepezil—Alzheimer's disease	0.000848	0.0013	CcSEcCtD
Vidarabine—Dizziness—Memantine—Alzheimer's disease	0.000813	0.00124	CcSEcCtD
Vidarabine—ADK—Metabolism—ATP5A1—Alzheimer's disease	0.000807	0.00381	CbGpPWpGaD
Vidarabine—Nausea—Donepezil—Alzheimer's disease	0.000804	0.00123	CcSEcCtD
Vidarabine—Dizziness—Rivastigmine—Alzheimer's disease	0.000795	0.00121	CcSEcCtD
Vidarabine—Vomiting—Memantine—Alzheimer's disease	0.000781	0.00119	CcSEcCtD
Vidarabine—Rash—Memantine—Alzheimer's disease	0.000775	0.00118	CcSEcCtD
Vidarabine—Dermatitis—Memantine—Alzheimer's disease	0.000774	0.00118	CcSEcCtD
Vidarabine—Headache—Memantine—Alzheimer's disease	0.00077	0.00118	CcSEcCtD
Vidarabine—ADK—Metabolism—PLD3—Alzheimer's disease	0.000769	0.00364	CbGpPWpGaD
Vidarabine—Vomiting—Rivastigmine—Alzheimer's disease	0.000764	0.00117	CcSEcCtD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—HTR6—Alzheimer's disease	0.000761	0.0036	CbGpPWpGaD
Vidarabine—Rash—Rivastigmine—Alzheimer's disease	0.000758	0.00116	CcSEcCtD
Vidarabine—Dermatitis—Rivastigmine—Alzheimer's disease	0.000757	0.00116	CcSEcCtD
Vidarabine—Headache—Rivastigmine—Alzheimer's disease	0.000753	0.00115	CcSEcCtD
Vidarabine—ADORA2A—Circadian rythm related genes—CHRNB2—Alzheimer's disease	0.000752	0.00355	CbGpPWpGaD
Vidarabine—ADORA2A—Circadian rythm related genes—CST3—Alzheimer's disease	0.000752	0.00355	CbGpPWpGaD
Vidarabine—ADORA2A—GPCRs, Other—CCR5—Alzheimer's disease	0.00075	0.00354	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—PSENEN—Alzheimer's disease	0.000743	0.00351	CbGpPWpGaD
Vidarabine—ADK—Metabolism—HSD17B10—Alzheimer's disease	0.000738	0.00349	CbGpPWpGaD
Vidarabine—ADORA2A—GPCRs, Other—HTR2A—Alzheimer's disease	0.000734	0.00347	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—APH1A—Alzheimer's disease	0.000732	0.00346	CbGpPWpGaD
Vidarabine—ADA—Circadian rythm related genes—PRKCG—Alzheimer's disease	0.000731	0.00345	CbGpPWpGaD
Vidarabine—Nausea—Memantine—Alzheimer's disease	0.00073	0.00112	CcSEcCtD
Vidarabine—ADORA2A—Monoamine Transport—TNF—Alzheimer's disease	0.000728	0.00344	CbGpPWpGaD
Vidarabine—ADA—Metabolism—DHCR24—Alzheimer's disease	0.000723	0.00342	CbGpPWpGaD
Vidarabine—Nausea—Rivastigmine—Alzheimer's disease	0.000714	0.00109	CcSEcCtD
Vidarabine—ADORA2A—Signaling by NGF—NCSTN—Alzheimer's disease	0.000713	0.00337	CbGpPWpGaD
Vidarabine—ADK—Metabolism—CYP46A1—Alzheimer's disease	0.00071	0.00336	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—MME—Alzheimer's disease	0.000707	0.00334	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—PYY—Alzheimer's disease	0.000694	0.00328	CbGpPWpGaD
Vidarabine—ADK—Metabolism—ND1—Alzheimer's disease	0.000686	0.00324	CbGpPWpGaD
Vidarabine—ADORA2A—Circadian rythm related genes—CRH—Alzheimer's disease	0.000683	0.00323	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—HSPD1—Alzheimer's disease	0.000657	0.00311	CbGpPWpGaD
Vidarabine—ADORA2A—Circadian rythm related genes—NPS—Alzheimer's disease	0.000647	0.00306	CbGpPWpGaD
Vidarabine—ADORA2A—Circadian rythm related genes—SLC6A4—Alzheimer's disease	0.000635	0.003	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—GAL—Alzheimer's disease	0.000632	0.00299	CbGpPWpGaD
Vidarabine—ADA—Circadian rythm related genes—LEP—Alzheimer's disease	0.00063	0.00298	CbGpPWpGaD
Vidarabine—ADA—Metabolism—CA4—Alzheimer's disease	0.000615	0.00291	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—NTRK2—Alzheimer's disease	0.000605	0.00286	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—GSK3A—Alzheimer's disease	0.0006	0.00284	CbGpPWpGaD
Vidarabine—ADA—Circadian rythm related genes—NOS2—Alzheimer's disease	0.000587	0.00277	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—PSEN2—Alzheimer's disease	0.00058	0.00274	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—HTR6—Alzheimer's disease	0.000579	0.00274	CbGpPWpGaD
Vidarabine—ADA—Metabolism—GAPDHS—Alzheimer's disease	0.000578	0.00273	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—EIF2S1—Alzheimer's disease	0.000555	0.00262	CbGpPWpGaD
Vidarabine—ADA—Circadian rythm related genes—PPARG—Alzheimer's disease	0.000549	0.00259	CbGpPWpGaD
Vidarabine—ADA—Metabolism—ATP5A1—Alzheimer's disease	0.000548	0.00259	CbGpPWpGaD
Vidarabine—ADA—Circadian rythm related genes—GSK3B—Alzheimer's disease	0.000546	0.00258	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—ACHE—Alzheimer's disease	0.000542	0.00256	CbGpPWpGaD
Vidarabine—ADA—Circadian rythm related genes—CREB1—Alzheimer's disease	0.000541	0.00256	CbGpPWpGaD
Vidarabine—ADORA2A—Circadian rythm related genes—NGFR—Alzheimer's disease	0.00053	0.0025	CbGpPWpGaD
Vidarabine—ADA—Metabolism—PLD3—Alzheimer's disease	0.000523	0.00247	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—CTSD—Alzheimer's disease	0.000513	0.00242	CbGpPWpGaD
Vidarabine—ADA—Metabolism—HSD17B10—Alzheimer's disease	0.000501	0.00237	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—NPY—Alzheimer's disease	0.000496	0.00235	CbGpPWpGaD
Vidarabine—ADA—Metabolism—CYP46A1—Alzheimer's disease	0.000483	0.00228	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—GAL—Alzheimer's disease	0.000481	0.00227	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—GSK3A—Alzheimer's disease	0.00048	0.00227	CbGpPWpGaD
Vidarabine—ADORA2A—Circadian rythm related genes—PPARGC1A—Alzheimer's disease	0.000474	0.00224	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—BCHE—Alzheimer's disease	0.000472	0.00223	CbGpPWpGaD
Vidarabine—ADA—Metabolism—ND1—Alzheimer's disease	0.000466	0.0022	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—NTRK2—Alzheimer's disease	0.000466	0.0022	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—GSK3A—Alzheimer's disease	0.000461	0.00218	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—ACE—Alzheimer's disease	0.000457	0.00216	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—NPS—Alzheimer's disease	0.000454	0.00215	CbGpPWpGaD
Vidarabine—ADK—Metabolism—TPI1—Alzheimer's disease	0.000442	0.00209	CbGpPWpGaD
Vidarabine—ADK—Metabolism—CHAT—Alzheimer's disease	0.000442	0.00209	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—SST—Alzheimer's disease	0.000433	0.00205	CbGpPWpGaD
Vidarabine—ADK—Metabolism—MAOB—Alzheimer's disease	0.000424	0.002	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—APP—Alzheimer's disease	0.000422	0.00199	CbGpPWpGaD
Vidarabine—ADORA2A—Circadian rythm related genes—PRKCG—Alzheimer's disease	0.00042	0.00198	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—MEF2C—Alzheimer's disease	0.00042	0.00198	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—PRKCG—Alzheimer's disease	0.000412	0.00195	CbGpPWpGaD
Vidarabine—ADK—Metabolism—GAPDH—Alzheimer's disease	0.000408	0.00193	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—NGF—Alzheimer's disease	0.000401	0.00189	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—NGFR—Alzheimer's disease	0.000399	0.00189	CbGpPWpGaD
Vidarabine—ADK—Metabolism—A2M—Alzheimer's disease	0.000394	0.00186	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—PYY—Alzheimer's disease	0.000392	0.00185	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—NPY—Alzheimer's disease	0.000378	0.00179	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—IAPP—Alzheimer's disease	0.000376	0.00178	CbGpPWpGaD
Vidarabine—ADA—Circadian rythm related genes—MAPK8—Alzheimer's disease	0.000368	0.00174	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—IGF2—Alzheimer's disease	0.000366	0.00173	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—CRH—Alzheimer's disease	0.000365	0.00172	CbGpPWpGaD
Vidarabine—ADORA2A—Circadian rythm related genes—LEP—Alzheimer's disease	0.000362	0.00171	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—PYY—Alzheimer's disease	0.000356	0.00168	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—CALM1—Alzheimer's disease	0.000356	0.00168	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—NPS—Alzheimer's disease	0.000346	0.00163	CbGpPWpGaD
Vidarabine—ADK—Metabolism—ACHE—Alzheimer's disease	0.000343	0.00162	CbGpPWpGaD
Vidarabine—ADK—Metabolism—INPP5D—Alzheimer's disease	0.000339	0.0016	CbGpPWpGaD
Vidarabine—ADORA2A—Circadian rythm related genes—NOS2—Alzheimer's disease	0.000337	0.00159	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—SST—Alzheimer's disease	0.00033	0.00156	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—HTR6—Alzheimer's disease	0.000327	0.00155	CbGpPWpGaD
Vidarabine—ADORA2A—GPCRs, Class A Rhodopsin-like—CCR5—Alzheimer's disease	0.000326	0.00154	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—MEF2C—Alzheimer's disease	0.000323	0.00152	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—APP—Alzheimer's disease	0.000321	0.00152	CbGpPWpGaD
Vidarabine—ADK—Metabolism—ENO1—Alzheimer's disease	0.000321	0.00152	CbGpPWpGaD
Vidarabine—ADK—Metabolism—PTGS1—Alzheimer's disease	0.000321	0.00152	CbGpPWpGaD
Vidarabine—ADORA2A—GPCRs, Class A Rhodopsin-like—HTR2A—Alzheimer's disease	0.000319	0.00151	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—PRKCG—Alzheimer's disease	0.000317	0.0015	CbGpPWpGaD
Vidarabine—ADORA2A—Circadian rythm related genes—PPARG—Alzheimer's disease	0.000315	0.00149	CbGpPWpGaD
Vidarabine—ADK—Metabolism—CYP2D6—Alzheimer's disease	0.000315	0.00149	CbGpPWpGaD
Vidarabine—ADORA2A—Circadian rythm related genes—GSK3B—Alzheimer's disease	0.000313	0.00148	CbGpPWpGaD
Vidarabine—ADORA2A—Circadian rythm related genes—CREB1—Alzheimer's disease	0.000311	0.00147	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CDK5—Alzheimer's disease	0.000309	0.00146	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—NGF—Alzheimer's disease	0.000308	0.00146	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—GSK3B—Alzheimer's disease	0.000307	0.00145	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—CREB1—Alzheimer's disease	0.000305	0.00144	CbGpPWpGaD
Vidarabine—ADA—Metabolism—CHAT—Alzheimer's disease	0.0003	0.00142	CbGpPWpGaD
Vidarabine—ADA—Metabolism—TPI1—Alzheimer's disease	0.0003	0.00142	CbGpPWpGaD
Vidarabine—ADK—Metabolism—BCHE—Alzheimer's disease	0.000298	0.00141	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—HTR6—Alzheimer's disease	0.000297	0.00141	CbGpPWpGaD
Vidarabine—ADA—Metabolism—MAOB—Alzheimer's disease	0.000288	0.00136	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—LEP—Alzheimer's disease	0.000284	0.00134	CbGpPWpGaD
Vidarabine—ADK—Metabolism—PLCB1—Alzheimer's disease	0.000282	0.00133	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCR5—Alzheimer's disease	0.000279	0.00132	CbGpPWpGaD
Vidarabine—ADA—Metabolism—GAPDH—Alzheimer's disease	0.000277	0.00131	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—CALM1—Alzheimer's disease	0.000274	0.00129	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Alzheimer's disease	0.000273	0.00129	CbGpPWpGaD
Vidarabine—ADK—Metabolism—ABCA1—Alzheimer's disease	0.000273	0.00129	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—GAL—Alzheimer's disease	0.000272	0.00129	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—F2—Alzheimer's disease	0.000268	0.00127	CbGpPWpGaD
Vidarabine—ADA—Metabolism—A2M—Alzheimer's disease	0.000268	0.00127	CbGpPWpGaD
Vidarabine—ADA—Circadian rythm related genes—TP53—Alzheimer's disease	0.000257	0.00121	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—GAL—Alzheimer's disease	0.000247	0.00117	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—INS—Alzheimer's disease	0.000243	0.00115	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—TTR—Alzheimer's disease	0.000241	0.00114	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—F2—Alzheimer's disease	0.000239	0.00113	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—CCL2—Alzheimer's disease	0.000239	0.00113	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—GSK3B—Alzheimer's disease	0.000236	0.00112	CbGpPWpGaD
Vidarabine—ADK—Metabolism—PPARGC1A—Alzheimer's disease	0.000235	0.00111	CbGpPWpGaD
Vidarabine—ADA—Circadian rythm related genes—IL6—Alzheimer's disease	0.000235	0.00111	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—IGF1—Alzheimer's disease	0.000235	0.00111	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—CREB1—Alzheimer's disease	0.000234	0.00111	CbGpPWpGaD
Vidarabine—ADK—Metabolism—HMOX1—Alzheimer's disease	0.000234	0.00111	CbGpPWpGaD
Vidarabine—ADA—Metabolism—ACHE—Alzheimer's disease	0.000233	0.0011	CbGpPWpGaD
Vidarabine—ADA—Metabolism—INPP5D—Alzheimer's disease	0.00023	0.00109	CbGpPWpGaD
Vidarabine—ADA—Metabolism—ENO1—Alzheimer's disease	0.000218	0.00103	CbGpPWpGaD
Vidarabine—ADA—Metabolism—PTGS1—Alzheimer's disease	0.000218	0.00103	CbGpPWpGaD
Vidarabine—ADK—Metabolism—LPL—Alzheimer's disease	0.000214	0.00101	CbGpPWpGaD
Vidarabine—ADA—Metabolism—CYP2D6—Alzheimer's disease	0.000214	0.00101	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—NPY—Alzheimer's disease	0.000214	0.00101	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCL2—Alzheimer's disease	0.000213	0.00101	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—CCR5—Alzheimer's disease	0.000213	0.001	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—IAPP—Alzheimer's disease	0.000212	0.001	CbGpPWpGaD
Vidarabine—ADORA2A—Circadian rythm related genes—MAPK8—Alzheimer's disease	0.000212	0.001	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PYY—Alzheimer's disease	0.00021	0.000995	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—HTR2A—Alzheimer's disease	0.000208	0.000983	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—CRH—Alzheimer's disease	0.000206	0.000974	CbGpPWpGaD
Vidarabine—ADA—Metabolism—BCHE—Alzheimer's disease	0.000203	0.000959	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—NPS—Alzheimer's disease	0.000195	0.000923	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—NPY—Alzheimer's disease	0.000194	0.000917	CbGpPWpGaD
Vidarabine—ADK—Metabolism—MTHFR—Alzheimer's disease	0.000193	0.000911	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—IAPP—Alzheimer's disease	0.000193	0.000911	CbGpPWpGaD
Vidarabine—ADA—Metabolism—PLCB1—Alzheimer's disease	0.000191	0.000905	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CRH—Alzheimer's disease	0.000187	0.000884	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—GAB2—Alzheimer's disease	0.000186	0.000881	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—SST—Alzheimer's disease	0.000186	0.000881	CbGpPWpGaD
Vidarabine—ADA—Metabolism—ABCA1—Alzheimer's disease	0.000186	0.000877	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CDK5—Alzheimer's disease	0.000182	0.000862	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—F2—Alzheimer's disease	0.000182	0.000862	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—APP—Alzheimer's disease	0.000182	0.000858	CbGpPWpGaD
Vidarabine—ADK—Metabolism—CALM1—Alzheimer's disease	0.00018	0.000852	CbGpPWpGaD
Vidarabine—ADK—Metabolism—APOE—Alzheimer's disease	0.00018	0.000849	CbGpPWpGaD
Vidarabine—ADK—Metabolism—CAV1—Alzheimer's disease	0.000178	0.000841	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—NPS—Alzheimer's disease	0.000177	0.000838	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—PPP3CA—Alzheimer's disease	0.000177	0.000834	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—HTR6—Alzheimer's disease	0.000176	0.00083	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—CASP3—Alzheimer's disease	0.000174	0.00082	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—PLCB1—Alzheimer's disease	0.000171	0.00081	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—SST—Alzheimer's disease	0.000169	0.0008	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—GAB2—Alzheimer's disease	0.000169	0.0008	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—APP—Alzheimer's disease	0.000165	0.000779	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—CCL2—Alzheimer's disease	0.000163	0.000768	CbGpPWpGaD
Vidarabine—ADA—Metabolism—PPARGC1A—Alzheimer's disease	0.00016	0.000756	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—MAPK8—Alzheimer's disease	0.00016	0.000754	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PSENEN—Alzheimer's disease	0.00016	0.000754	CbGpPWpGaD
Vidarabine—ADA—Metabolism—HMOX1—Alzheimer's disease	0.000159	0.000752	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—APH1A—Alzheimer's disease	0.000157	0.000743	CbGpPWpGaD
Vidarabine—ADK—Metabolism—PPARG—Alzheimer's disease	0.000156	0.000739	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—PLCB1—Alzheimer's disease	0.000156	0.000735	CbGpPWpGaD
Vidarabine—ADK—Metabolism—INS—Alzheimer's disease	0.000153	0.000725	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—NCSTN—Alzheimer's disease	0.000153	0.000724	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—LRP1—Alzheimer's disease	0.000149	0.000706	CbGpPWpGaD
Vidarabine—ADORA2A—Circadian rythm related genes—TP53—Alzheimer's disease	0.000148	0.000697	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—GFAP—Alzheimer's disease	0.000146	0.000689	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—GAL—Alzheimer's disease	0.000146	0.000689	CbGpPWpGaD
Vidarabine—ADA—Metabolism—LPL—Alzheimer's disease	0.000146	0.000688	CbGpPWpGaD
Vidarabine—ADORA2A—Circadian rythm related genes—IL6—Alzheimer's disease	0.000135	0.000638	CbGpPWpGaD
Vidarabine—ADK—Metabolism—NOS3—Alzheimer's disease	0.000135	0.000636	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—IL6—Alzheimer's disease	0.000132	0.000626	CbGpPWpGaD
Vidarabine—ADA—Metabolism—MTHFR—Alzheimer's disease	0.000131	0.00062	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—A2M—Alzheimer's disease	0.000129	0.000608	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—PRKCG—Alzheimer's disease	0.000127	0.000599	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PSEN2—Alzheimer's disease	0.000125	0.000588	CbGpPWpGaD
Vidarabine—ADK—Metabolism—PTGS2—Alzheimer's disease	0.000123	0.000581	CbGpPWpGaD
Vidarabine—ADA—Metabolism—CALM1—Alzheimer's disease	0.000122	0.000579	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—AKT1—Alzheimer's disease	0.000122	0.000577	CbGpPWpGaD
Vidarabine—ADA—Metabolism—APOE—Alzheimer's disease	0.000122	0.000577	CbGpPWpGaD
Vidarabine—ADA—Metabolism—CAV1—Alzheimer's disease	0.000121	0.000571	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—CCR5—Alzheimer's disease	0.00012	0.000568	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—HTR2A—Alzheimer's disease	0.000118	0.000555	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—PRKCG—Alzheimer's disease	0.000115	0.000544	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—NPY—Alzheimer's disease	0.000115	0.000542	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—IAPP—Alzheimer's disease	0.000114	0.000538	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CRH—Alzheimer's disease	0.000111	0.000522	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CCR5—Alzheimer's disease	0.000109	0.000515	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—HTR2A—Alzheimer's disease	0.000107	0.000504	CbGpPWpGaD
Vidarabine—ADA—Metabolism—PPARG—Alzheimer's disease	0.000106	0.000502	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—NPS—Alzheimer's disease	0.000105	0.000495	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PPP3CA—Alzheimer's disease	0.000104	0.000493	CbGpPWpGaD
Vidarabine—ADA—Metabolism—INS—Alzheimer's disease	0.000104	0.000493	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—F2—Alzheimer's disease	0.000103	0.000487	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PTK2B—Alzheimer's disease	0.000103	0.000486	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—IL6—Alzheimer's disease	0.000102	0.000481	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—GAB2—Alzheimer's disease	0.0001	0.000472	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—SST—Alzheimer's disease	0.0001	0.000472	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—NTRK2—Alzheimer's disease	0.0001	0.000472	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CALM1—Alzheimer's disease	9.96e-05	0.000471	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—GSK3A—Alzheimer's disease	9.91e-05	0.000468	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—APP—Alzheimer's disease	9.74e-05	0.00046	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—AKT1—Alzheimer's disease	9.4e-05	0.000444	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—F2—Alzheimer's disease	9.36e-05	0.000442	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PLCB1—Alzheimer's disease	9.19e-05	0.000434	CbGpPWpGaD
Vidarabine—ADA—Metabolism—NOS3—Alzheimer's disease	9.14e-05	0.000432	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—NGFR—Alzheimer's disease	8.58e-05	0.000405	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CREB1—Alzheimer's disease	8.52e-05	0.000403	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—ADAM10—Alzheimer's disease	8.38e-05	0.000396	CbGpPWpGaD
Vidarabine—ADA—Metabolism—PTGS2—Alzheimer's disease	8.36e-05	0.000395	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CCL2—Alzheimer's disease	8.34e-05	0.000394	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—S100B—Alzheimer's disease	7.92e-05	0.000374	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—IGF2—Alzheimer's disease	7.54e-05	0.000356	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—IGF1R—Alzheimer's disease	7.29e-05	0.000345	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—LPL—Alzheimer's disease	6.99e-05	0.00033	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—MEF2C—Alzheimer's disease	6.93e-05	0.000328	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PRKCG—Alzheimer's disease	6.8e-05	0.000321	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—NGF—Alzheimer's disease	6.62e-05	0.000313	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CCR5—Alzheimer's disease	6.44e-05	0.000304	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—HTR2A—Alzheimer's disease	6.31e-05	0.000298	CbGpPWpGaD
Vidarabine—ADK—Metabolism—AKT1—Alzheimer's disease	6.18e-05	0.000292	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CALM1—Alzheimer's disease	5.88e-05	0.000278	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—LEP—Alzheimer's disease	5.86e-05	0.000277	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—APOE—Alzheimer's disease	5.86e-05	0.000277	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CAV1—Alzheimer's disease	5.81e-05	0.000274	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—ESR1—Alzheimer's disease	5.6e-05	0.000264	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—F2—Alzheimer's disease	5.53e-05	0.000261	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—NOTCH1—Alzheimer's disease	5.41e-05	0.000256	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—GSK3B—Alzheimer's disease	5.08e-05	0.00024	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CREB1—Alzheimer's disease	5.04e-05	0.000238	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—INS—Alzheimer's disease	5.01e-05	0.000237	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CCL2—Alzheimer's disease	4.93e-05	0.000233	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—IGF1—Alzheimer's disease	4.84e-05	0.000229	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—NOS3—Alzheimer's disease	4.39e-05	0.000208	CbGpPWpGaD
Vidarabine—ADA—Metabolism—AKT1—Alzheimer's disease	4.2e-05	0.000199	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—AKT1—Alzheimer's disease	3.76e-05	0.000178	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CASP3—Alzheimer's disease	3.73e-05	0.000176	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—IL6—Alzheimer's disease	3.7e-05	0.000175	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—MAPK8—Alzheimer's disease	3.43e-05	0.000162	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—AKT1—Alzheimer's disease	3.42e-05	0.000161	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—VEGFA—Alzheimer's disease	3.16e-05	0.00015	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—TGFB1—Alzheimer's disease	2.9e-05	0.000137	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—TP53—Alzheimer's disease	2.39e-05	0.000113	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—IL6—Alzheimer's disease	2.19e-05	0.000103	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—AKT1—Alzheimer's disease	2.02e-05	9.54e-05	CbGpPWpGaD
